These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11776694)

  • 61. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis.
    Franceschi F; Sepulveda AR; Gasbarrini A; Pola P; Silveri NG; Gasbarrini G; Graham DY; Genta RM
    Circulation; 2002 Jul; 106(4):430-4. PubMed ID: 12135941
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The role of infection in the pathogenesis of atherosclerosis].
    Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
    Przegl Epidemiol; 2004; 58(4):671-6. PubMed ID: 15810509
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chlamydia pneumoniae in atherosclerotic tissue.
    Taylor-Robinson D; Thomas BJ
    J Infect Dis; 2000 Jun; 181 Suppl 3():S437-40. PubMed ID: 10839732
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Viruses and atherosclerosis].
    Capron L
    Rev Prat; 1990 Oct; 40(24):2227-33. PubMed ID: 2175447
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions.
    Rassu M; Cazzavillan S; Scagnelli M; Peron A; Bevilacqua PA; Facco M; Bertoloni G; Lauro FM; Zambello R; Bonoldi E
    Atherosclerosis; 2001 Sep; 158(1):73-9. PubMed ID: 11500176
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Viral theory of atherosclerosis. Role of cytomegalovirus].
    Bayad J; Galteau MM; Siest G
    Ann Biol Clin (Paris); 1993; 51(2):101-7. PubMed ID: 8214807
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells.
    Triantafilou M; Gamper FG; Lepper PM; Mouratis MA; Schumann C; Harokopakis E; Schifferle RE; Hajishengallis G; Triantafilou K
    Cell Microbiol; 2007 Aug; 9(8):2030-9. PubMed ID: 17419716
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?
    Kuo C; Campbell LA
    Mol Med Today; 1998 Oct; 4(10):426-30. PubMed ID: 9793930
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dental plaque, platelets, and cardiovascular diseases.
    Herzberg MC; Weyer MW
    Ann Periodontol; 1998 Jul; 3(1):151-60. PubMed ID: 9722699
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].
    Stille W; Dittmann R
    Herz; 1998 May; 23(3):185-92. PubMed ID: 9646100
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Infection and coronary atherosclerosis: the role Chlamydia pneumonia].
    Paz M; de Otero J; Codinach P; Ferrer-Ruscalleda F; Gayà M; Ibernón M
    Rev Esp Cardiol; 1998 Nov; 51(11):857-63. PubMed ID: 9859707
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Atherosclerosis--a chronic infectious disease caused by Chlamydia pneumoniae].
    Stille W; Stephen C
    Versicherungsmedizin; 1999 Mar; 51(1):12-7. PubMed ID: 10200611
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Infectious burden and atherosclerosis: A clinical issue.
    Sessa R; Pietro MD; Filardo S; Turriziani O
    World J Clin Cases; 2014 Jul; 2(7):240-9. PubMed ID: 25032197
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease.
    Maass M; Bartels C; Krüger S; Krause E; Engel PM; Dalhoff K
    Atherosclerosis; 1998 Oct; 140 Suppl 1():S25-30. PubMed ID: 9859922
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chlamydia pneumoniae seropositivity and systemic and renovascular atherosclerotic disease.
    van der Ven AJ; Hommels MJ; Kroon AA; Kessels A; Flobbe K; van Engelshoven J; Bruggeman CA; de Leeuw PW
    Arch Intern Med; 2002 Apr; 162(7):786-90. PubMed ID: 11926852
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of infectious agents by polymerase chain reaction in human aortic wall.
    Reszka E; Jegier B; Wasowicz W; Lelonek M; Banach M; Jaszewski R
    Cardiovasc Pathol; 2008; 17(5):297-302. PubMed ID: 18402822
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients.
    Jha HC; Srivastava P; Divya A; Prasad J; Mittal A
    APMIS; 2009 Dec; 117(12):905-11. PubMed ID: 20078556
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathogenesis of atherosclerosis: a possible relation to infection.
    Noll G
    Atherosclerosis; 1998 Oct; 140 Suppl 1():S3-9. PubMed ID: 9859918
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of infectious burden on the prevalence of atopy and respiratory allergies in Iceland, Estonia, and Sweden.
    Janson C; Asbjornsdottir H; Birgisdottir A; Sigurjonsdottir RB; Gunnbjörnsdottir M; Gislason D; Olafsson I; Cook E; Jögi R; Gislason T; Thjodleifsson B
    J Allergy Clin Immunol; 2007 Sep; 120(3):673-9. PubMed ID: 17586034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.